Answers are grounded in this paper and cite their sources.
Experimental study reveals nitrogen cold atmospheric plasma reduces pruritus in mouse models and cell lines, indicating a potential non-pharmacological therapy for chronic itch.
Chronic pruritus is a highly prevalent symptom that markedly impairs the quality of life in both humans and animals. Although pharmacological therapies, including Janus kinase (JAK) inhibitors, are widely used for itch management, long-term treatment is associated with adverse effects and increased patient burden. Therefore, the development of non-pharmacological antipruritic approaches is highly desired. In this study, we investigated the antipruritic effects of nitrogen gas-derived cold atmospheric plasma (N 2 -CAP) and explored its underlying mechanisms using behavioral and calcium imaging analyses. Intradermal administration of an N 2 -CAP-treated solution (CAP water) significantly suppressed histamine- and serotonin-induced scratching and capsaicin-induced pain-related behaviors in mice. In vitro calcium imaging revealed that CAP water significantly reduced dorsal root ganglion (DRG) neuronal responses to histamine, serotonin, capsaicin, allyl isothiocyanate (AITC), and compound 48/80. Furthermore, CAP water modulated pruritogen-induced Ca 2+ responses in human keratinocytes (HaCaT cells) and canine keratinocytes (CPEK cells), suggesting that N 2 -CAP influences neurocutaneous signaling pathways in both human and veterinary species. In a mouse model of allergic contact dermatitis, intradermal administration of CAP water significantly reduced scratching behavior, with an efficacy comparable to that of oclacitinib, a clinically used JAK inhibitor. Moreover, CAP treatment suppressed histamine- and AITC-induced DRG neuronal activation more strongly than did oclacitinib. Collectively, these findings demonstrated that N 2 -CAP exerts antipruritic effects by modulating peripheral sensory neurons and epidermal keratinocytes. Therefore, N 2 -CAP may represent a novel non-pharmacological or adjunctive therapeutic strategy for chronic pruritus in both human and veterinary medicine.
No takes yet. Share an insight, caveat, or question.
Komai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: